Genetic architecture of cytokine autoantibodies and associated risk of common diseases
- Jakob Hjorth von Stemann
- Joseph Dowsett
- Rebecca Svanberg Teglgaard
- Maria Didriksen
- Frederikke Byron Pedersen
- Mette Skou Bentsen
- Andrea Barghetti
- Maria Vispe Laguarda
- Sara Louise Borregaard Larsen
- Bente Glintborg
- Ulrik Lassen
- Ruth Frikke-Schmidt
- Celeste Porsbjerg
- Jens-Ulrik Stæhr Jensen
- Thomas Werge
- Andrew J. Schork
- Johan Skov Bundgaard
- Henning Bundgaard
- Torben Hansen
- Jakob Bay
- Jens Kjærgaard Boldsen
- Søren Brunak
- Nanna Brøns
- Alfonso Buil Demur
- Lea Arregui Nordahl Christoffersen
- Khoa Manh Dinh
- Josephine Gladov
- Daniel F. Gudbjartsson
- Thomas Folkmann Hansen
- Dorte Helenius Mikkelsen
- Lotte Hindhede
- Henrik Hjalgrim
- Kathrine Agergård Kaspersen
- Bertram Dalskov Kjerulff
- Lisette Kogelman
- Mette Kongstad
- Susan Mikkelsen
- Line Hjorth Stjernholm Nielsen
- Janna Nissen
- Mette Nyegaard
- Liam James Elgaard Quinn
- Þórunn Rafnar
- Palle Duun Rohde
- Klaus Rostgaard
- Michael Schwinn
- Kari Stefansson
- Hreinn Stefansson
- Jacob Træholt
- Unnur Þorsteinsdóttir
- Henrik Ullum
2026-08-22
Anti-cytokine autoantibodies are increasingly recognized as modulators of immune function and determinants of disease risk, yet their genetic basis and population-level impact remain unclear. Here we perform genome-wide association studies of autoantibodies against IL-1α, IL-6, IL-10, IFN-α, IFN-β, IFN-γ and GM-CSF in 15,000 individuals from the Danish Blood Donor Study. We identify 52 genome-wide significant loci, implicating genes enriched in antigen-presentation pathways. Using these data, we derive cytokine-specific polygenic risk scores and evaluate their associations across 300,000 individuals in the Copenhagen Hospital Biobank. Genetic predisposition to IL-1α autoantibodies is associated with reduced risk of rheumatoid arthritis and certain cancers, whereas genetic predisposition to IL-6 autoantibodies is associated with increased risk of diabetes, mirroring prior clinical observations. These findings define the genetic architecture of anti-cytokine autoantibodies and indicate their divergent effects on human disease risk at population scale, providing a framework for mechanistic investigation and potential clinical stratification.